SAN DIEGO, CA / ACCESSWIRE / April 30, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of Myriad Genetics, Inc. (NASDAQ: MYGN).

Investors who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 19, 2018. NASDAQ: MYGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On March 12, 2018, Myriad Genetics, Inc disclosed that it had received a subpoena from the Department of Health and Human Services, Office of Inspector General, in connection with "an investigation into possible false or otherwise improper claims submitted for payment under Medicare and Medicaid," specifically relating to Myriad Genetics, Inc's hereditary cancer testing. The subpoena covers a time period from January 1, 2014 - less than four months after the September 2013 launch of Myriad's myRisk test - through the date of the subpoena's issuance.

On April 20, 2018, a lawsuit was filed against Myriad Genetics, Inc. over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that Myriad was submitting false or otherwise improper claims for payment under Medicare and Medicaid for the Company's hereditary cancer testing, that the foregoing conduct would foreseeably subject Myriad to heightened regulatory scrutiny and/or enforcement action, that Myriad's revenues from its hereditary cancer testing were in part the product of improper conduct and unlikely to be sustainable, and that as a result, Myriad's public statements were materially false and misleading at all relevant times.

Those who purchased Myriad Genetics, Inc. (NASDAQ: MYGN) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.